SEC Form 4 · accession 0001055726-16-000058
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 2:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2016 | M | 245,300 | $5.08 | A | 2,066,508 | D | |
| Common Stock | Jun 8, 2016 | F | 110,866 | $11.24 | D | 1,955,642 | D | |
| Common Stock | holding | — | — | — | 1,750,000 | I | By Family Limited Partnership | |
| Common Stock | holding | — | — | — | 33,563 | I | By Daughter: EK | |
| Common Stock | holding | — | — | — | 33,775 | I | By Son: JK1 | |
| Common Stock | holding | — | — | — | 5,975 | I | By Spouse | |
| Common Stock | holding | — | — | — | 33,533 | I | By Son: JK2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock OptionF1 | $5.08 | Jun 8, 2016 | M | 245,300 | D | May 1, 2006 | Jun 10, 2016 | Common Stock | 245,300 | 0 | D |
Explanation of responses
- F1The term of these stock options was extended by 30 days after the expiration of the Company's blackout period.